Clinical impact of preformed donor‐specific denatured class I HLA antibodies after kidney transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|5|393-402

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.5, 2015-05, pp. : 393-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donor‐specific anti‐HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for the development of donor‐specific antibodies after pediatric heart transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 8, 2015-12 ,pp. : 906-910

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum complement inactivation unveiled prepregnancy donor‐specific HLA antibodies leading to postpartum kidney graft loss

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 5, 2015-05 ,pp. : 623-625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early immunosuppression treatment correlates with later de novo donor‐specific antibody development after kidney and pancreas transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1119-1127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donor‐Specific HLA‐Antibodies: The Difficulty of Separating the Wheat From the Chaff

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 4, 2015-04 ,pp. : 861-862

John Wiley & Sons Inc

Access to resources Recommend Favorite